Skip to main content
padlock icon - secure page this page is secure

Potential of Indonesian Plants (Annona muricata, Garcinia latissima, and Garcinia celebica) Against Hepatitis C Virus

Buy Article:

$106.65 + tax (Refund Policy)

Development of antiviral drugs for the treatment of Hepatitis C obtained from medicinal plants is an alternative or additional treatment in the therapy of hepatitis C. In this study, we are focused on screening the anti-HCV activity against JFH1 strain genotype 2a with using Indonesia plants including Annona muricata from leaves, and Garcinia latissima and Garcinia celebica from stem bark. The extractions used maceration method were started from n-hexane solvent and the residue continues used methanol solvent for Annona muricata and Garcinia latissima, while Garcinia celebica used acetone solvent. The extracts were then examined with a single dose 20 μg/mL for anti-HCV activity against JFH1 strain genotype 2a and cytotoxicity against Huh7it-1 cell line. Annona muricata and Garcinia celebica extracts exhibited no infection (0%) of HCV and low infections (5.7%) of Garcinia latissima extract. No apparent cytotoxicity was observed in Huh7it-1 cells treated on Garcinia latissima extract, while on Annona muricata and Garcinia celebica extracts exhibited toxicity was high 81.3% and 99.7% against cell line Huh7it-1. These results suggest that Annona muricata, Garcinia latissima and Garcinia celebica have potential as anti-HCV. Further study, purification of the active compounds is required to know the antiviral compound against HCV.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Annona muricata; Garcinia celebica.; Garcinia latissima; Hepatitis C Virus

Document Type: Research Article

Affiliations: 1: Division of Microbiology, Faculty of Medicine, Universitas Swadaya Gunung Jati, Cirebon, Indonesia 2: Department of International Health, Kobe University Graduate School of Health Sciences, 7-10-2, Tomogaoka, Suma-ku, Kobe 654-0142, Japan 3: Research Center for Chemistry, Indonesian Institute of Sciences (LIPI), Kawasan Puspiptek, Serpong 15310, Indonesia 4: Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia 5: Department of Oral Vaccine and Drug Development, Kobe University Graduate School of Health Sciences, 1-5-6 Minatojima-minamimachi, Chou-ku, Kobe 650-0047, Japan

Publication date: September 1, 2018

More about this publication?
  • ADVANCED SCIENCE LETTERS is an international peer-reviewed journal with a very wide-ranging coverage, consolidates research activities in all areas of (1) Physical Sciences, (2) Biological Sciences, (3) Mathematical Sciences, (4) Engineering, (5) Computer and Information Sciences, and (6) Geosciences to publish original short communications, full research papers and timely brief (mini) reviews with authors photo and biography encompassing the basic and applied research and current developments in educational aspects of these scientific areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more